Skip to content

Clinical trials

Coronavirus Infections trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Coronavirus Infections Clear all

1,111 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20032
20041
20101
20112
20152
20162
20172
20186
20195
2020745
2021195
202274
202328
202412
202511
20268

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed643
Unknown status216
Terminated122
Withdrawn58
Recruiting32
Active, not recruiting13
No longer available9
Suspended7
Not yet recruiting6
Enrolling by invitation3
Available2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Institute of Allergy and Infectious Diseases (NIAID)33
ModernaTX, Inc.30
BioNTech SE14
University of Oxford11
Assistance Publique - Hôpitaux de Paris10
Columbia University10
University of Milano Bicocca8
University of Minnesota8
Ain Shams University7
Johns Hopkins University7

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Coronavirus Infections1,111
COVID-19784
Severe Acute Respiratory Syndrome110
Virus Diseases94
Pneumonia62
Respiratory Distress Syndrome57
Pneumonia, Viral39
Respiratory Tract Infections33
Coronaviridae Infections28
RNA Virus Infections28

Trials

Showing 26 to 50 of 1,111. Each trial links to its page on Pharma Observatory.

1,011 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.